DouglassAlanDrelichMD

PubMed

• Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years aft...
  Robbin Itzler, Tyler W Buckner, Frank W G Leebeek, Joel Miller, Michael Recht, Douglass Drelich, Paul E Monahan, Steven W Pipe> ;Haemophilia. 2024 Mar 10
• The current challenges faced by people with hemophilia B.
  Miesbach, W., Smith, C., Pinachyan, K., Bensen-Kennedy, D., von Drygalski, A., Sivamurthy, K., Drelich, D., Kulkarni, R.> ;European Journal of Haematology. 2024 Mar 1
• Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment ...
  Guillet, B., Yan, S., Hooper, B., Steenkamp, J., Tomic, R., Mancuso, M., Drelich, D.> ;Advances in Therapy. 2024 Feb 1
• 6 citations
  Perioperative Outcomes of Patients with Bleeding Disorders Undergoing Major Surgery at an Academic Hemophilia Treatment Center.
  Ruben Rhoades, Zachary French, Amy Yang, Karen Walsh, Douglass A Drelich, Steven E McKenzie> ;Clinical and Applied Thrombosis/hemostasis. 2023 Mar 27
• 3 citations
  Successful liver transplant from a hemophilia A donor with no development of hemophilia A in recipient
  Christine Kurian, Douglass A. Drelich, Sanaa Rizk> ;Journal of Thrombosis and Haemostasis. 2020 Apr 1
• 8 citations
  Immunoglobulin therapy and thrombosis: coincidence or causation?
  Douglass A. Drelich, Paul F. Bray, Jay H. Herman> ;Transfusion. 2012 Oct 1
• Join now to see all